Addus HomeCare Corporation ADUS
NASDAQ · United States · Health Services
$110.54-2.42 (-2.14%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
When examining a long-term compounder, astute market participants look past quarterly headlines to evaluate core operational drivers, margin stability, and pricing power. Addus HomeCare (NASDAQ:ADUS) embodies many classic characteristics of a durable portfolio holding: a sticky, non-franchise personal care delivery model, consistent organic growth, and a disciplined approach to capital allocation across fragmented regional markets. […]
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Addus HomeCare (ADUS) heads into its 2026 Jefferies Healthcare Services and Technology Conference appearance with fresh attention on its AccentCare personal care acquisition and the stock’s recent sector driven move. After a strong run that produced a 23.45% 90 day share price return and lifted year to date share price gains to 8.73%, Addus HomeCare has seen momentum cool slightly in the last week as investors weigh the AccentCare deal, evolving Medicaid headlines, and the stock’s longer term...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.